<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article article-type="editorial" dtd-version="2.3" xml:lang="EN" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Pharmacol.</journal-id>
<journal-title>Frontiers in Pharmacology</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Pharmacol.</abbrev-journal-title>
<issn pub-type="epub">1663-9812</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="publisher-id">868784</article-id>
<article-id pub-id-type="doi">10.3389/fphar.2022.868784</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Pharmacology</subject>
<subj-group>
<subject>Editorial</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Editorial: Therapeutic Index for Nutraceuticals in Inflammation-Related Diseases: Efficacy, Bioavailability, Metabolism and Interactions With Drugs, Volume II</article-title>
<alt-title alt-title-type="left-running-head">Peluso and Palmery</alt-title>
<alt-title alt-title-type="right-running-head">Editorial: Therapeutic Index for Nutraceuticals</alt-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Peluso</surname>
<given-names>Ilaria</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="corresp" rid="c001">&#x2a;</xref>
<uri xlink:href="https://loop.frontiersin.org/people/572115/overview"/>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Palmery</surname>
<given-names>Maura</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<xref ref-type="corresp" rid="c001">&#x2a;</xref>
<uri xlink:href="https://loop.frontiersin.org/people/594793/overview"/>
</contrib>
</contrib-group>
<aff id="aff1">
<sup>1</sup>
<institution>Research Centre for Food and Nutrition</institution>, <institution>Council for Agricultural Research and Economics (CREA-AN)</institution>, <addr-line>Rome</addr-line>, <country>Italy</country>
</aff>
<aff id="aff2">
<sup>2</sup>
<institution>Department of Physiology and Pharmacology &#x201c;Vittorio Erspamer&#x201d;</institution>, <institution>Faculty of Pharmacy and Medicine</institution>, <institution>Sapienza University of Rome</institution>, <addr-line>Rome</addr-line>, <country>Italy</country>
</aff>
<author-notes>
<fn fn-type="edited-by">
<p>
<bold>Edited and reviewed by:</bold> <ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/10035/overview">Paola Patrignani</ext-link>, University of Studies G. d&#x2019;Annunzio Chieti and Pescara, Italy</p>
</fn>
<corresp id="c001">&#x2a;Correspondence: Ilaria Peluso, <email>ilaria.peluso@crea.gov.it</email>; Maura Palmery, <email>maura.palmery@uniroma1.it</email>
</corresp>
<fn fn-type="other">
<p>This article was submitted to Inflammation Pharmacology, a section of the journal Frontiers in Pharmacology</p>
</fn>
</author-notes>
<pub-date pub-type="epub">
<day>23</day>
<month>03</month>
<year>2022</year>
</pub-date>
<pub-date pub-type="collection">
<year>2022</year>
</pub-date>
<volume>13</volume>
<elocation-id>868784</elocation-id>
<history>
<date date-type="received">
<day>03</day>
<month>02</month>
<year>2022</year>
</date>
<date date-type="accepted">
<day>09</day>
<month>02</month>
<year>2022</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#xa9; 2022 Peluso and Palmery.</copyright-statement>
<copyright-year>2022</copyright-year>
<copyright-holder>Peluso and Palmery</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these&#x20;terms.</p>
</license>
</permissions>
<related-article id="RA1" related-article-type="commentary-article" journal-id="Front. Pharmacol." xlink:href="https://www.frontiersin.org/research-topics/21764" ext-link-type="uri">Editorial on the Research Topic <article-title>Therapeutic Index for Nutraceuticals in Inflammation-Related Diseases: Efficacy, Bioavailability, Metabolism and Interactions with Drugs, Volume II</article-title>
</related-article>
<kwd-group>
<kwd>bioactive compounds</kwd>
<kwd>functional foods</kwd>
<kwd>medicinal plants</kwd>
<kwd>inflammation</kwd>
<kwd>oxidative stress</kwd>
<kwd>pharmacokenetics</kwd>
</kwd-group>
</article-meta>
</front>
<body>
<sec sec-type="intro" id="s1">
<title>Introduction</title>
<p>This Frontiers Research Topic is part of a series (<ext-link ext-link-type="uri" xlink:href="https://www.frontiersin.org/research-topics/8685/therapeutic-index-for-nutraceuticals-in-inflammation-related-diseases-efficacy-bioavailability-metab">https://www.frontiersin.org/research-topics/8685/therapeutic-index-for-nutraceuticals-in-inflammation-related-diseases-efficacy-bioavailability-metab</ext-link>) that aims to collect preclinical (<italic>in&#x20;vitro</italic> and <italic>in vivo</italic>) and human studies to evaluate the therapeutic index for natural occurring phytochemicals based on their molecular targets, metabolism, pharmacokinetic, and potential interactions with drugs, examining interindividual variations (redox, inflammatory, immune and healthy/disease status, genetic polymorphisms, microbiota diversity).</p>
</sec>
<sec id="s2">
<title>Issue Content</title>
<p>This issue includes two research papers and two review articles. Concerning the problem of the low bioavailability of bioactive phytochemicals, <ext-link ext-link-type="uri" xlink:href="https://www.frontiersin.org/articles/10.3389/fphar.2021.725362/full">Wang et&#x20;al.</ext-link> studied the effects of Piperine (PIP) in rats, examining its artificial synthetic analog, silepcimide (ILE) on the pharmacokinetics of curcumin (CUR). In addition to PIP, ILE, and CUR, the authors evaluated the plasma concentration of the metabolite of CUR dihydrocurcumin (DHC). After combined administration of CUR and ILE, Cmax, T1/2, and the AUC (0-tn) of DHC increased, whereas Tmax decreased. Besides, results from experiments of intravenous injection/oral administration, and of reactions with small intestine homogenate without microbes of SD rats, suggest the involvement of the gastrointestinal microorganisms. The role of gut microbiota is described in the review of <ext-link ext-link-type="uri" xlink:href="https://www.frontiersin.org/articles/10.3389/fphar.2021.709629/full">Yang et&#x20;al.</ext-link>, in the context of the effects of berberine (BBR) in atherosclerotic cardiovascular and metabolic diseases, in view of its low bioavailability. BBR modulates the composition of the gut microbiota and the gut microbe-dependent metabolites and reduces the inflammation induced by gut microbiota-derived lipopolysaccharide (LPS). The latter has been used in a Zebrafish model of inflammation in the work of <ext-link ext-link-type="uri" xlink:href="https://www.frontiersin.org/articles/10.3389/fphar.2021.751576/full">Balkrishna et&#x20;al.</ext-link>, aimed at evaluating the anti-inflammatory effect of the Ayurvedic medicinal food, Patanjali Special Chyawanprash (PSCP). PSCP reduced the hyperventilation and the loss of physical activeness in zebrafish due to inflammation, as well as the expression levels of pro-inflammatory cytokines, including interleukin-6 (IL-6), tumor necrosis factor alpha (TNF-&#x3b1;), and interleukin-1 beta (IL-1&#x3b2;). Moreover, from the results in THP-1 cells, the authors suggested the involvement of the nuclear factor kappa-B (NF-&#x3ba;B). In the review of <ext-link ext-link-type="uri" xlink:href="https://www.frontiersin.org/articles/10.3389/fphar.2021.762182/full">Anaeigoudari et&#x20;al.</ext-link> the inhibition of NF-&#x3ba;B is among the mechanisms reported for Nigella sativa and catechin. In the &#x201c;<italic>Highlights</italic>&#x201d; of their work, the authors suggested that active compounds from Nigella sativa L., Camellia sinensis L., and Allium sativum L. showed antidiabetic, anti-inflammatory, antioxidant, lipolysis, hepatoprotective, and cardioprotective effects.</p>
</sec>
<sec id="s3">
<title>Context and Futures Directions</title>
<p>The Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) outbreak has led to an increase in investigations of the potential role of bioactive molecules from natural sources on human health and virus infections, as described in other Frontiers Research Topics (<ext-link ext-link-type="uri" xlink:href="https://www.frontiersin.org/research-topics/14125/ethnopharmacological-responses-to-the-coronavirus-disease-2019-covid-19-pandemic">https://www.frontiersin.org/research-topics/14125/ethnopharmacological-responses-to-the-coronavirus-disease-2019-covid-19-pandemic</ext-link>; <ext-link ext-link-type="uri" xlink:href="https://www.frontiersin.org/research-topics/16489/biomolecules-against-coronaviruses-molecular-aspects-multi-omics-and-systems-pharmacology">https://www.frontiersin.org/research-topics/16489/biomolecules-against-coronaviruses-molecular-aspects-multi-omics-and-systems-pharmacology</ext-link>; <ext-link ext-link-type="uri" xlink:href="https://www.frontiersin.org/research-topics/14960/plant-products-for-antiviral-therapeutics">https://www.frontiersin.org/research-topics/14960/plant-products-for-antiviral-therapeutics</ext-link>; <ext-link ext-link-type="uri" xlink:href="https://www.frontiersin.org/research-topics/17117/emerging-and-old-viral-diseases-antiviral-drug-discovery-from-medicinal-plants">https://www.frontiersin.org/research-topics/17117/emerging-and-old-viral-diseases-antiviral-drug-discovery-from-medicinal-plants</ext-link>; <ext-link ext-link-type="uri" xlink:href="https://www.frontiersin.org/research-topics/30920/emerging-and-old-viral-diseases-antiviral-drug-discovery-from-medicinal-plants-volume-ii">https://www.frontiersin.org/research-topics/30920/emerging-and-old-viral-diseases-antiviral-drug-discovery-from-medicinal-plants-volume-ii</ext-link>; <ext-link ext-link-type="uri" xlink:href="https://www.frontiersin.org/research-topics/19696/natural-products-as-potential-therapeutics-to-tackle-life-threatening-infections-from-field-to-marke">https://www.frontiersin.org/research-topics/19696/natural-products-as-potential-therapeutics-to-tackle-life-threatening-infections-from-field-to-marke</ext-link>). Although the antioxidant and anti-inflammatory effects of nutraceuticals may help to avoid the cytokine storms induced by the coronavirus disease 2019 (COVID-19), self-medication is a growing phenomenon (<ext-link ext-link-type="uri" xlink:href="https://www.frontiersin.org/articles/10.3389/fphar.2020.582154/full">Haque et&#x20;al.</ext-link>; <xref ref-type="bibr" rid="B6">Tekeba et&#x20;al., 2021</xref>; <xref ref-type="bibr" rid="B7">Wegbom et&#x20;al., 2021</xref>), as well as online medication purchasing (<xref ref-type="bibr" rid="B4">Jairoun et&#x20;al., 2021</xref>; <xref ref-type="bibr" rid="B3">Fincham 2021</xref>). In the context of possible interventions against misinformation (including nutraceuticals, vitamins, and immune boosters) and the abuse of over-the-counter (OTC) medicines (<xref ref-type="bibr" rid="B1">Al Mazrouei et&#x20;al., 2021</xref>; <xref ref-type="bibr" rid="B5">Marwitz 2021</xref>), the potential interactions between nutraceuticals and drugs require more attention. OTC are freely sold at pharmacies, parapharmacies, and supermarkets and <xref ref-type="bibr" rid="B2">Bertuccioli et&#x20;al. (2022)</xref> recently reviewed the potential nutraceutical-drugs interactions of many botanicals, including case reports. The major limitation of the present issue is that it does not include this topic, despite it being one of the aims of the Research Topic.</p>
</sec>
</body>
<back>
<sec id="s4">
<title>Author Contributions</title>
<p>All authors listed have made a substantial, direct, and intellectual contribution to the work and approved it for publication.</p>
</sec>
<sec sec-type="COI-statement" id="s5">
<title>Conflict of Interest</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
<sec sec-type="disclaimer" id="s6">
<title>Publisher&#x2019;s Note</title>
<p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p>
</sec>
<ack>
<p>We greatly appreciate the invaluable contribution of all authors and reviewers.</p>
</ack>
<ref-list>
<title>References</title>
<ref id="B1">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Al Mazrouei</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Ibrahim</surname>
<given-names>R. M.</given-names>
</name>
<name>
<surname>Al Meslamani</surname>
<given-names>A. Z.</given-names>
</name>
<name>
<surname>Abdel-Qader</surname>
<given-names>D. H.</given-names>
</name>
<name>
<surname>Mohamed Ibrahim</surname>
<given-names>O.</given-names>
</name>
</person-group> (<year>2021</year>). <article-title>Virtual Pharmacist Interventions on Abuse of Over-the-counter Medications during COVID-19 versus Traditional Pharmacist Interventions</article-title>. <source>J.&#x20;Am. Pharm. Assoc. (2003)</source> <volume>61</volume> (<issue>3</issue>), <fpage>331</fpage>&#x2013;<lpage>339</lpage>. <pub-id pub-id-type="doi">10.1016/j.japh.2021.02.003</pub-id> </citation>
</ref>
<ref id="B2">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bertuccioli</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Cardinali</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Di Pierro</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Magi</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Zonzini</surname>
<given-names>G.</given-names>
</name>
</person-group> (<year>2022</year>). <article-title>A Practical Perspective on the Use of Botanicals during the COVID-19 Pandemic: From Proven to Potential Interactions</article-title>. <source>J.&#x20;Med. Food</source> <volume>25</volume> (<issue>1</issue>), <fpage>1</fpage>&#x2013;<lpage>11</lpage>. <pub-id pub-id-type="doi">10.1089/jmf.2021.0062</pub-id> </citation>
</ref>
<ref id="B3">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fincham</surname>
<given-names>J.&#x20;E.</given-names>
</name>
</person-group> (<year>2021</year>). <article-title>Negative Consequences of the Widespread and Inappropriate Easy Access to Purchasing Prescription Medications on the Internet</article-title>. <source>Am. Health Drug Benefits</source> <volume>14</volume> (<issue>1</issue>), <fpage>22</fpage>&#x2013;<lpage>28</lpage>. </citation>
</ref>
<ref id="B4">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jairoun</surname>
<given-names>A. A.</given-names>
</name>
<name>
<surname>Al-Hemyari</surname>
<given-names>S. S.</given-names>
</name>
<name>
<surname>Abdulla</surname>
<given-names>N. M.</given-names>
</name>
<name>
<surname>El-Dahiyat</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Jairoun</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Al-Tamimi</surname>
<given-names>S. K.</given-names>
</name>
<etal/>
</person-group> (<year>2021</year>). <article-title>Online Medication Purchasing during the Covid-19 Pandemic: Potential Risks to Patient Safety and the Urgent Need to Develop More Rigorous Controls for Purchasing Online Medications, a Pilot Study from the United Arab Emirates</article-title>. <source>J.&#x20;Pharm. Pol. Pract</source> <volume>14</volume> (<issue>1</issue>), <fpage>38</fpage>. <pub-id pub-id-type="doi">10.1186/s40545-021-00320-z</pub-id> </citation>
</ref>
<ref id="B5">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Marwitz</surname>
<given-names>K. K.</given-names>
</name>
</person-group> (<year>2021</year>). <article-title>The Pharmacist&#x27;s Active Role in Combating COVID-19 Medication Misinformation</article-title>. <source>J.&#x20;Am. Pharm. Assoc. (2003)</source> <volume>61</volume>, <fpage>e71</fpage>&#x2013;<lpage>e74</lpage>. <pub-id pub-id-type="doi">10.1016/j.japh.2020.10.022</pub-id> </citation>
</ref>
<ref id="B6">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tekeba</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Ayele</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Negash</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Gashaw</surname>
<given-names>T.</given-names>
</name>
</person-group> (<year>2021</year>). <article-title>Extent of and Factors Associated with Self-Medication Among Clients Visiting Community Pharmacies in the Era of COVID-19: Does it Relieve the Possible Impact of the Pandemic on the Health-Care System?</article-title> <source>Risk Manag. Healthc. Pol.</source> <volume>14</volume>, <fpage>4939</fpage>&#x2013;<lpage>4951</lpage>. <pub-id pub-id-type="doi">10.2147/RMHP.S338590</pub-id> </citation>
</ref>
<ref id="B7">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wegbom</surname>
<given-names>A. I.</given-names>
</name>
<name>
<surname>Edet</surname>
<given-names>C. K.</given-names>
</name>
<name>
<surname>Raimi</surname>
<given-names>O.</given-names>
</name>
<name>
<surname>Fagbamigbe</surname>
<given-names>A. F.</given-names>
</name>
<name>
<surname>Kiri</surname>
<given-names>V. A.</given-names>
</name>
</person-group> (<year>2021</year>). <article-title>Self-Medication Practices and Associated Factors in the Prevention And/or Treatment of COVID-19 Virus: A Population-Based Survey in Nigeria</article-title>. <source>Front. Public Health</source> <volume>9</volume>, <fpage>606801</fpage>. <pub-id pub-id-type="doi">10.3389/fpubh.2021.606801</pub-id> </citation>
</ref>
</ref-list>
</back>
</article>